Form 13-F position report

ELEDON PHARMACEUTICALS INC

Reported by 22NW LP

ELDN CUSIP 28617K101 Manager CIK 0001694297

Reported 636,364 shares, unchanged from the prior quarter.

Reported value -35.8%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 1.12% This manager · Q3 2026
Shares 636,364 Quarter-end amount reported
Reported value $1,610,001 Fair value at quarter end
Consecutive quarters held 7 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 2157274
2025-06-30 1724546
2025-09-30 1648183
2025-12-31 960910
2026-03-31 1960001
2026-06-30 2507274
2026-09-30 1610001

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for ELEDON PHARMACEUTICALS INC held by 22NW LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 636,364 0 (0.0%) 1.12% $1,610,001 2026-11-13
Q2 2026 Unchanged 636,364 0 (0.0%) 2.4% $2,507,274 2026-08-14
Q1 2026 Unchanged 636,364 0 (0.0%) 1.34% $1,960,001 2026-05-15
Q4 2025 Unchanged 636,364 0 (0.0%) 0.4% $960,910 2026-02-13
Q3 2025 Unchanged 636,364 0 (0.0%) 0.78% $1,648,183 2025-11-14
Q2 2025 Unchanged 636,364 0 (0.0%) 1.09% $1,724,546 2025-08-14
Q1 2025 New 636,364 +636,364 (0.0%) 1.45% $2,157,274 2025-05-14

Who else reported the position

180 managers reported ELEDON PHARMACEUTICALS INC for Q3 2026.

Managers reporting ELEDON PHARMACEUTICALS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 6,641,297 +1,517,455 < 0.01% $16,802,480 9 qtrs
BVF INC IL Unchanged 6,293,282 0 0.52% $15,922,003 23 qtrs
Defilade Capital Management L P Unchanged 3,525,338 0 1.49% $8,919,105 4 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Unchanged 3,417,223 0 < 0.01% $8,645,574 3 qtrs
The Goldman Sachs Group Inc Added 2,561,285 +50,977 < 0.01% $6,480,051 8 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,980,977 +24,376 < 0.01% $5,013,079 23 qtrs
Ensign Peak Advisors Inc Reduced 1,756,223 -345,001 < 0.01% $4,443,244 24 qtrs
Catalio Capital Management LP Reduced 1,637,114 -57,957 0.77% $4,141,898 5 qtrs
STATE STREET CORPORATION Reduced 1,614,898 -7,071 < 0.01% $4,085,692 22 qtrs
SPHERA FUNDS MANAGEMENT LTD Added 1,392,187 +201,000 0.5% $3,522,233 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
636,364
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.